Clinical trial
Austrian Cholesterol Screening And Treatment II (ACT II)
NCT01381679 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Austrian Cholesterol Screening And Treatment II (ACT II)
- Lead sponsor
- Organon and Co
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2009
- Completion date
- December 31, 2010
- Enrollment
- 1,682 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.